The third one billion Chinese patent medicine for the digestive system may be born!

According to the latest data from Minet.

New high! Jiangzhong and Taiji "lead" the tens of billions market

Sales of proprietary Chinese medicines in the terminal digestive system of physical pharmacies in cities in China in recent years (unit: 100 million yuan)

Source: Mi Nei.

The latest data from Mi Nei.

In recent years, the market share of TOP5 subcategories of Chinese patent medicines in the terminal digestive system of physical pharmacies in cities in China

Source: Mi Nei.

Among the 13 sub-categories of Chinese patent medicines for the digestive system, the five major subcategories of stomach medicine, stomach medicine (gastritis, ulcer), heat-relieving medicine, liver disease medicine, and hemorrhoid medicine are the most popular, with a total market share of nearly 80%

2021E China's urban entity pharmacies terminal digestive system patented Chinese medicine manufacturers TOP3

Source: Mi Nei.

From the perspective of manufacturers, Jiangzhong Pharmaceutical, Taiji Group Chongqing Fuling Pharmaceutical, Zhangzhou Pien Tzehuang Pharmaceutical, Jiangxi Kang Enbei Chinese Medicine, and Mayinglong Pharmaceutical Group rank firmly in the top five

The third one billion Chinese patent medicine for the digestive system may be born! TOP20 rankings have changed, 11 exclusive products are dazzling

2021E TOP20 Chinese patent medicine products in the terminal digestive system of physical pharmacies in cities in China (unit: 100 million yuan)

Source: Mi Nei.

The sales of TOP20 products exceeded 100 million yuan.

In recent years, Jianwei Xiaoshi Tablets have steadily increased their terminal sales in physical pharmacies in Chinese cities, and are expected to exceed the 1.

Huoxiang Zhengqi Oral Liquid was listed in the "New Coronavirus Pneumonia Diagnosis and Treatment Plan" by the National Health Commission in 2020.

In terms of treatment categories, stomach-invigorating and dispelling medicines and anti-heat agents are the most, with 4 each; followed by stomach medicines (gastritis, ulcer) and hemorrhoids, with 3 each

2021E TOP20 Chinese proprietary Chinese medicine brands in the terminal digestive system of physical pharmacies in cities in China (unit: 100 million yuan)

Source: Mi Nei.

Note: Less than 100 million yuan is represented by *

18 brands of TOP20 have sales of more than 100 million yuan.

In terms of growth rate, Kunming Traditional Chinese Medicine's Shenling Jianpiwei Granule has the fastest growth rate, exceeding 60%; Hebei Wanbang Fulin Pharmaceutical's new compound aloe capsules, exceeding 20%; Jiangxi Kang Enbei Chinese Medicine's Changyanning Tablet, Sichuan Good Doctor Panxi Pharmaceutical's Kangfu New Liquid, Tasly Pharmaceutical Group's Huoxiang Zhengqi Dropping Pills, and Daxing Pharmaceutical's Zhenglu Pills all exceeded 10%

Jianmin, Kangyuan, Jingxin.

New Chinese patent medicines for the digestive system that have been applied for listing/clinical since 2019

Source: Meinenet MED2.
0 Chinese Drug Evaluation Database

Since 2019, only Chinese patent medicines for the digestive system have been approved for marketing in Sangzhi total alkaloid tablets from Beijing Wuhe Boao Pharmaceutical.
This product is China's first approved new Chinese medicine for diabetes in the past 10 years
.

Two new drugs were submitted for marketing applications and are under review and approval.
Jianmin Pharmaceutical Group’s Liwei Capsule is used for chronic non-atrophic gastritis with erosion and damp-heat stasis syndrome, and Shandong Phoenix Pharmaceutical’s Qihuang Capsule is a new drug for the treatment of diabetic nephropathy
.
In addition, Zhejiang Jingxin Pharmaceutical's Kangfuxin Enteric-coated Capsules, Jiangsu Kangyuan Pharmaceutical | Beijing Huayi Shennong Pharmaceutical's Cistanche Runtong Oral Liquid and other 10 new drugs have been approved for clinical use
.
From the perspective of subcategories of treatment, diabetes medications, liver disease medications, and stomach medications (gastritis, ulcers) are the hottest
.

Source: Mi Nei.
com database, company announcements, etc.

Please correct me if there are any errors or omissions
.

Note: China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product at the terminal
.